Response to Comment on Pietropaolo et al. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2– Infected Young Individuals: Is It Type 1 Diabetes? Diabetes 2022;71:2656–2663

Detalles Bibliográficos
Autores principales: Pietropaolo, Massimo, Hotez, Peter, Giannoukakis, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2022
Materias:
e-Letters – Comments and Responses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862292/
https://www.ncbi.nlm.nih.gov/pubmed/36409787
http://dx.doi.org/10.2337/db22-0347
_version_ 1784875056935993344
author Pietropaolo, Massimo
Hotez, Peter
Giannoukakis, Nick
author_facet Pietropaolo, Massimo
Hotez, Peter
Giannoukakis, Nick
author_sort Pietropaolo, Massimo
collection PubMed
description
format Online
Article
Text
id pubmed-9862292
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-98622922023-02-03 Response to Comment on Pietropaolo et al. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2– Infected Young Individuals: Is It Type 1 Diabetes? Diabetes 2022;71:2656–2663 Pietropaolo, Massimo Hotez, Peter Giannoukakis, Nick Diabetes e-Letters – Comments and Responses American Diabetes Association 2022-12 2022-11-21 /pmc/articles/PMC9862292/ /pubmed/36409787 http://dx.doi.org/10.2337/db22-0347 Text en © 2022 by the American Diabetes Association https://www.diabetesjournals.org/journals/pages/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license.
spellingShingle e-Letters – Comments and Responses
Pietropaolo, Massimo
Hotez, Peter
Giannoukakis, Nick
Response to Comment on Pietropaolo et al. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2– Infected Young Individuals: Is It Type 1 Diabetes? Diabetes 2022;71:2656–2663
title Response to Comment on Pietropaolo et al. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2– Infected Young Individuals: Is It Type 1 Diabetes? Diabetes 2022;71:2656–2663
title_full Response to Comment on Pietropaolo et al. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2– Infected Young Individuals: Is It Type 1 Diabetes? Diabetes 2022;71:2656–2663
title_fullStr Response to Comment on Pietropaolo et al. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2– Infected Young Individuals: Is It Type 1 Diabetes? Diabetes 2022;71:2656–2663
title_full_unstemmed Response to Comment on Pietropaolo et al. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2– Infected Young Individuals: Is It Type 1 Diabetes? Diabetes 2022;71:2656–2663
title_short Response to Comment on Pietropaolo et al. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2– Infected Young Individuals: Is It Type 1 Diabetes? Diabetes 2022;71:2656–2663
title_sort response to comment on pietropaolo et al. incidence of an insulin-requiring hyperglycemic syndrome in sars-cov-2– infected young individuals: is it type 1 diabetes? diabetes 2022;71:2656–2663
topic e-Letters – Comments and Responses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862292/
https://www.ncbi.nlm.nih.gov/pubmed/36409787
http://dx.doi.org/10.2337/db22-0347
work_keys_str_mv AT pietropaolomassimo responsetocommentonpietropaoloetalincidenceofaninsulinrequiringhyperglycemicsyndromeinsarscov2infectedyoungindividualsisittype1diabetesdiabetes20227126562663
AT hotezpeter responsetocommentonpietropaoloetalincidenceofaninsulinrequiringhyperglycemicsyndromeinsarscov2infectedyoungindividualsisittype1diabetesdiabetes20227126562663
AT giannoukakisnick responsetocommentonpietropaoloetalincidenceofaninsulinrequiringhyperglycemicsyndromeinsarscov2infectedyoungindividualsisittype1diabetesdiabetes20227126562663

Ejemplares similares